2025 annual financial data
Dianthus Therapeutics 2025 Operating margin
Dianthus Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -8,739.34%.
Operating income was -177,933,000 USD and net income was -162,337,000 USD.
Operating cash flow was -129,060,000 USD.
Get free Dianthus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,036,000 USD
- Operating income
- -177,933,000 USD
- Net income
- -162,337,000 USD
- Operating cash flow
- -129,060,000 USD